Page last updated: 2024-08-26

melanotan-ii and Innate Inflammatory Response

melanotan-ii has been researched along with Innate Inflammatory Response in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hellberg, S; Knuuti, J; Koskinen, E; Liljenbäck, H; Nuutinen, S; Rinne, P; Roivainen, A; Salomäki, H; Saraste, A; Saukko, P; Savontaus, E; Silvola, JM; Ståhle, M	1
Baumane, L; Dambrova, M; Kalvinsh, I; Liepinsh, E; Muceniece, R; Vilskersts, R; Wikberg, JE; Zvejniece, L	1

Other Studies

2 other study(ies) available for melanotan-ii and Innate Inflammatory Response

Article	Year
Pharmacological activation of the melanocortin system limits plaque inflammation and ameliorates vascular dysfunction in atherosclerotic mice. Arteriosclerosis, thrombosis, and vascular biology, 2014, Volume: 34, Issue:7 Topics: alpha-MSH; Animals; Anti-Inflammatory Agents; Aorta; Apolipoproteins B; Atherosclerosis; Biomarkers; Diet, High-Fat; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; Inflammation; Inflammation Mediators; Lipids; Macrophages; Male; Mice; Mice, Knockout; Peptides, Cyclic; Phenotype; Plaque, Atherosclerotic; Radionuclide Imaging; Receptors, LDL; Receptors, Melanocortin; Signal Transduction; Vasodilation; Vasodilator Agents	2014
Functional evaluation of THIQ, a melanocortin 4 receptor agonist, in models of food intake and inflammation. Basic & clinical pharmacology & toxicology, 2007, Volume: 101, Issue:6 Topics: alpha-MSH; Animals; Anti-Inflammatory Agents; Body Weight; Brain; Disease Models, Animal; Dose-Response Relationship, Drug; Eating; Electron Spin Resonance Spectroscopy; Inflammation; Injections, Intraventricular; Lipopolysaccharides; Male; Mice; Mice, Inbred ICR; Nitric Oxide; Peptides, Cyclic; Rats; Rats, Wistar; Receptor, Melanocortin, Type 4; Tetrahydroisoquinolines; Triazoles	2007

Article

Year

Pharmacological activation of the melanocortin system limits plaque inflammation and ameliorates vascular dysfunction in atherosclerotic mice.

Arteriosclerosis, thrombosis, and vascular biology, 2014, Volume: 34, Issue:7

Topics: alpha-MSH; Animals; Anti-Inflammatory Agents; Aorta; Apolipoproteins B; Atherosclerosis; Biomarkers; Diet, High-Fat; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; Inflammation; Inflammation Mediators; Lipids; Macrophages; Male; Mice; Mice, Knockout; Peptides, Cyclic; Phenotype; Plaque, Atherosclerotic; Radionuclide Imaging; Receptors, LDL; Receptors, Melanocortin; Signal Transduction; Vasodilation; Vasodilator Agents

2014

Functional evaluation of THIQ, a melanocortin 4 receptor agonist, in models of food intake and inflammation.

Basic & clinical pharmacology & toxicology, 2007, Volume: 101, Issue:6

Topics: alpha-MSH; Animals; Anti-Inflammatory Agents; Body Weight; Brain; Disease Models, Animal; Dose-Response Relationship, Drug; Eating; Electron Spin Resonance Spectroscopy; Inflammation; Injections, Intraventricular; Lipopolysaccharides; Male; Mice; Mice, Inbred ICR; Nitric Oxide; Peptides, Cyclic; Rats; Rats, Wistar; Receptor, Melanocortin, Type 4; Tetrahydroisoquinolines; Triazoles

2007